PP3M

paliperidone palmitate 3-month formulation · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PP3M, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study of PP3M in Patients With Schizophrenia [NA]